Transcatheter arterial chemoembolization (TACE), typically used for treating liver metastases from colorectal cancer, was applied to locally advanced rectal tumors in a study. Known as transcatheter rectal arterial chemoembolization (TRACE), the treatment was administered to 111 patients with stage II or III rectal tumors. The results showed a pathological complete response in 20.7% of patients and a major pathological response in 48.65%. Nearly 62% of patients were disease-free at 5 years, and almost 75% were alive at 5 years. The researchers suggest incorporating TRACE into the standard treatment strategy for patients with locally advanced rectal cancer. The study was published in Clinical Oncology and funded by the Third Military Medical University in China.
Source link
Transcatheter Arterial Chemoembolization for Rectal Tumors?
